The Role of Nitric oxide (NO) Donors in the Treatment of Male Infertility.
Nitric oxide
fertilisation capacity
male infertility
reactive oxygen species
reproductive biology.
treatment options
Journal
Current pharmaceutical design
ISSN: 1873-4286
Titre abrégé: Curr Pharm Des
Pays: United Arab Emirates
ID NLM: 9602487
Informations de publication
Date de publication:
Historique:
received:
31
03
2020
accepted:
04
08
2020
pubmed:
14
11
2020
medline:
25
2
2023
entrez:
13
11
2020
Statut:
ppublish
Résumé
Male infertility is a global problem and the number of men suffering from this condition has increased dramatically over the last decade. Currently, approximately 10-15% of couples have been affected by this worldwide. Although this is a crucial problem, treatment options are limited and sometimes even ineffective. In order to arrest this worrisome increase, the development of new treatment strategies has become fundamental. Redox regulation driven by NO in reproductive biology represents a novel pathway in male infertility and it plays a crucial role in maintaining normal fertilisation capacity. Compelling evidence states that ROS synthesis and degradation should be in perfect balance and tightly regulated by endogenous and exogenous antioxidant enzymes. NO donor drugs might play a beneficial role in restoring this fragile equilibrium and have shown great potential in ameliorating overall fertilisation capacity.
Identifiants
pubmed: 33183193
pii: CPD-EPUB-111462
doi: 10.2174/1381612826666201112144828
doi:
Substances chimiques
Antioxidants
0
Nitric Oxide Donors
0
Reactive Oxygen Species
0
Nitric Oxide
31C4KY9ESH
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2784-2789Informations de copyright
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.